Extension of Loan Repayment

Summary by AI ^BETAClose X

Wellnex Life Limited has secured an extension for the repayment of approximately $2.88 million in loans to former directors, now due by July 21, 2026, with an option to extend to August 21, 2026, for an additional $50,000 fee, both amounts to be added to the loan principal. The company will pay $150,000 for the initial extension, and interest will accrue at 10% on the principal, with accelerated repayment possible upon receiving funds from a corporate transaction. Additionally, former CEO Zack Bozinovski will provide advisory services as a consultant.

Disclaimer*

Wellnex Life Limited

23 April 2026

ASX/AIM Announcement

23 April 2026

Extension of Loan Repayment

Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") announces an extension to the previously announced repayment of the loans to former directors totalling circa $2.88 million (including interest), which were due for repayment by 20 April 2026. The Company and the former directors have now agreed an extension, with full repayment of all outstanding amounts due by no later than 21 July 2026. The Company has agreed to pay the former directors a total of $150,000, to be rolled into the loan principal, in consideration for the agreement of the extension. The repayment date may be extended to 21 August 2026 for a further payment of, in aggregate, $50,000 to the former directors to be rolled into the loan principal. Interest will accrue at the rate of 10% on the loan principal. The Company is required to make accelerated repayment (hence less interest payable) if it receives cleared funds from the proceeds of a corporate transaction, including but not limited to the sale of any of the Company's assets or a capital raising, which gives the Company sufficient cash proceeds to repay the Loan.

In addition, the Company is pleased to announce that it has agreed with former CEO Zack Bozinovski to work with Company as consultant providing advisory and project-based services.

This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

--- END ---

For further information, please contact:

Wellnex Life Limited (ASX/AIM:WNX)

Eric Jiang

Interim Executive Chairman

E: eric.j@wellnexlife.com.au

UK Investors

Strand Hanson (Financial & Nominated Advisor)

James Harris / Richard Johnson Tel: +44 (0) 20 7409 3494

Orana Corporate LLP (Joint Broker) swykeham@oranacorp.com

Sebastian Wykeham

S.P. Angel Corporate Finance LLP (Joint Broker) Tel: +44 (0)20 3470 0470

David Hignell / Vadim Alexandre

To learn more, please visit: https://wellnexlife.com.au/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END